LOC105369830: A Drug Target / Disease Biomarker (G105369830)
LOC105369830: A Drug Target / Disease Biomarker
LOC105369830 is a protein that is expressed in various tissues throughout the body. It is a member of the heat shock protein (HSP) family, which are proteins that are involved in the regulation of protein synthesis and folding. HSPs are highly conserved across different species, and they play a crucial role in ensuring the stability and integrity of various cellular structures.
LOC105369830 is of particular interest as a potential drug target or biomarker because of its ability to interact with a variety of small molecules, including drugs. This protein has been shown to be involved in a wide range of cellular processes, including cell signaling, DNA replication, and protein folding. As such, it is a promising target for small molecules that are aimed at modulating these processes.
One of the key ways in which LOC105369830 can be targeted with drugs is through its role in cell signaling. This protein is involved in a variety of signaling pathways, including the regulation of cell growth, differentiation, and survival. It is also involved in the regulation of cell-cell interactions and in the development of cancer. As such, drugs that are able to modulate these signaling pathways could be effective in treating a wide range of diseases.
Another way in which LOC105369830 can be targeted with drugs is through its role in DNA replication. This protein is involved in the regulation of DNA replication, and it has been shown to play a crucial role in ensuring the accuracy and fidelity of this process. Mutations in LOC105369830 have been associated with a variety of genetic diseases, including cancer. As such, drugs that are able to modulate DNA replication processes could be effective in treating these diseases as well.
LOC105369830 is also involved in the regulation of protein folding, a process that is critical for the production and function of a wide range of proteins. As such, drugs that are able to modulate protein folding processes could be effective in treating a wide range of diseases, including those that are caused by the misfolding of proteins.
In addition to its role in cell signaling, DNA replication, and protein folding, LOC105369830 is also involved in the regulation of cell-cell interactions. This protein is involved in the development and maintenance of tight junctions, which are a type of cell-cell adhesion that is critical for the proper functioning of tissues. As such, drugs that are able to modulate tight junction formation could be effective in treating a wide range of diseases, including those that are caused by the disruption of cell-cell adhesion.
Finally, LOC105369830 is also involved in the regulation of inflammation. This protein is involved in the production and response to inflammation, and it has been shown to play a crucial role in the development of a variety of inflammatory diseases. As such, drugs that are able to modulate inflammation processes could be effective in treating these diseases as well.
In conclusion, LOC105369830 is a protein that is involved in a wide range of cellular processes that are important for the proper functioning of tissues. As such, it is a promising target for small molecules that are aimed at modulating these processes. While further research is needed to fully understand the role of LOC105369830 in disease, its potential as a drug target or biomarker is significant.
Protein Name: Uncharacterized LOC105369830, Transcript Variant X2
The "LOC105369830 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105369830 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC105369833 | LOC105369835 | LOC105369838 | LOC105369843 | LOC105369844 | LOC105369850 | LOC105369862 | LOC105369869 | LOC105369879 | LOC105369890 | LOC105369896 | LOC105369923 | LOC105369927 | LOC105369928 | LOC105369944 | LOC105369958 | LOC105369965 | LOC105369976 | LOC105369998 | LOC105370002 | LOC105370003 | LOC105370011 | LOC105370025 | LOC105370027 | LOC105370032 | LOC105370050 | LOC105370073 | LOC105370076 | LOC105370108 | LOC105370109 | LOC105370113 | LOC105370115 | LOC105370127 | LOC105370128 | LOC105370134 | LOC105370135 | LOC105370165 | LOC105370168 | LOC105370174 | LOC105370176 | LOC105370182 | LOC105370204 | LOC105370214 | LOC105370222 | LOC105370243 | LOC105370259 | LOC105370262 | LOC105370273 | LOC105370275 | LOC105370286 | LOC105370302 | LOC105370311 | LOC105370312 | LOC105370321 | LOC105370324 | LOC105370328 | LOC105370355 | LOC105370359 | LOC105370384 | LOC105370399 | LOC105370420 | LOC105370429 | LOC105370438 | LOC105370452 | LOC105370455 | LOC105370470 | LOC105370476 | LOC105370481 | LOC105370497 | LOC105370500 | LOC105370504 | LOC105370507 | LOC105370519 | LOC105370529 | LOC105370536 | LOC105370544 | LOC105370546 | LOC105370547 | LOC105370548 | LOC105370549 | LOC105370557 | LOC105370572 | LOC105370574 | LOC105370575 | LOC105370577 | LOC105370579 | LOC105370582 | LOC105370614 | LOC105370616 | LOC105370617 | LOC105370619 | LOC105370627 | LOC105370645 | LOC105370660 | LOC105370706 | LOC105370721 | LOC105370740 | LOC105370819 | LOC105370826 | LOC105370832
